by Annabel Sedgwick
Share
by Annabel Sedgwick
Share
Microban® International – the global leader in antimicrobial additives and odor control solutions – has released a statement discrediting unwarranted claims about the safety and efficacy of antimicrobial technologies. This statement is intended to ensure that the public, consumers, and other stakeholders are equipped to make fully informed decisions, based on scientific reasoning. Making a clear distinction between public health and non-public health claims, Microban has explained the advantages of incorporating its antimicrobial additives into building materials to protect articles from degradation by mold, mildew, and odor-causing microbes. In doing so, the company openly supports the circular economy systemic approach – a collective movement away from single-use products and towards sustainability in construction – by extending the expected lifetime of products. In addition, the company has clarified that the actions of embedded antimicrobials do not contribute to antibiotic resistance, with support from peer-reviewed literature.
Microban is a trusted name with over 35 years of scientific, marketing and regulatory knowledge, ensuring that every claim is supported by comprehensive validation testing and is in line with regulation policies from the Biocidal Products Regulation (BPR) and Environmental Protection Agency (EPA) where appropriate. In its successful pursuit to ‘redefine clean’ for products and surfaces, Microban has supported its partners in leveraging advertising claims with the appropriate language and science-based conclusions.
Joe Lyons, President of Microban International, stated: “At Microban, we pride ourselves on always being an open, honest, and trusted leader in the sector. As demand for antimicrobial additives increases, this has never been more important. Our devoted teams are committed to informing our partners and the general public of the inherent benefits of treating products with built-in antimicrobial technology for reducing biodegradation and odor while increasing durability. With this statement, we hope to reassure consumers that our portfolio of antimicrobial technologies is backed by thorough scientific evidence and globally recognized test methods, so that they can have the correct information to make their own decisions.”
Click here to read the declaration on antimicrobials in building products from Microban.
About Microban International
Part of Barr Brands International (BBI), Microban International is a global specialist in antimicrobial, odor control, smart surface and disinfection technologies. Our proactive systems keep products cleaner, and control odors better by preventing problems before they start. Microban drives innovation by combining science and creative solutions that enhance high-quality consumer, textile, industrial and medical products around the world. Today the Microban brand and technologies are featured on thousands of products worldwide. The company is headquartered in North Carolina with operations in North America, Europe and Asia Pacific. For more information, please visit www.microban.com.
Anion dysregulation is seen in numerous diseases, from cystic fibrosis and chronic pain, to autism and cancer. Researchers at the University of Dallas are investigating anion transport in vivo, developing novel tools to help analyze the effects of both normal and aberrant anion regulation at the molecular level, and are using INTEGRA’s PIPETBOY acu 2 to streamline their cell
June Medical is one of 48 organisations to be recognised for their excellence in innovation in this year’s Queen’s Awards for Enterprise. Now in its 55th year, the Queen’s Awards for Enterprise are the most prestigious business awards in the country – rewarding only the most outstanding achievements – with winning businesses able to use the esteemed
A report from the International Agency for Research on Cancer1 recently classified TiO2 as ‘possibly carcinogenic to humans’ by inhalation and similarly, the European Chemicals Agency2 recommended TiO2 be classified as a category 2 carcinogen (suspected of causing cancer). In contrast, antimicrobial technologies from Microban International are based on SilverShield®, the first patented antimicrobial solution
INTEGRA Biosciences’ VIAFLO electronic pipettes are helping denovoMATRIX in Dresden, Germany, to produce modular, biomimetic coatings for cell culture plasticware that can be tailored to recreate a large variety of conditions for testing adherent cell cultures. Chief Scientific Officer Dr Richard Wetzel explained: “We have developed a range of pre-coated cell culture plasticware – screenMATRIX and myMATRIX – and